Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Checkpoint Inhibitor”

683 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 683 results

Testing effectiveness (Phase 2)Study completedNCT05086627
What this trial is testing

Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Hebei Medical University Fourth Hospital 118
Not applicableEnded earlyNCT05812274
What this trial is testing

Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Columbia University 30
Not applicableNot Yet RecruitingNCT07645742
What this trial is testing

Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors

Who this might be right for
Cancer (Advanced Stage)
West Virginia University 90
Testing effectiveness (Phase 2)Looking for participantsNCT07495215
What this trial is testing

A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection

Who this might be right for
Hepatocellular Carcinoma (HCC)
Yinghua Xu 20
Not applicableStudy completedNCT06007274
What this trial is testing

Troponin to Detect Major Cardiovasculaire Advserse Events on Immune Checkpoint Inhibitors

Who this might be right for
CancerImmune Checkpoint InhibitorCardiovascular Biomarkers
Institut Mutualiste Montsouris 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT03277638
What this trial is testing

Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)

Who this might be right for
Glioblastoma, Adult
Case Comprehensive Cancer Center 32
Testing effectiveness (Phase 2)Ended earlyNCT04260256
What this trial is testing

A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors

Who this might be right for
Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit
CellSight Technologies, Inc. 9
Testing effectiveness (Phase 2)UnknownNCT05311566
What this trial is testing

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

Who this might be right for
Cervical CarcinomaChemoradiotherapyAnti-programmed Cell Death Receptor 1+6 more
Lei Li 92
Not applicableLooking for participantsNCT05810402
What this trial is testing

Liver Cancer and Immunotherapy in the Liquid Biopsy Era

Who this might be right for
Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma+2 more
University Hospital, Montpellier 60
Testing effectiveness (Phase 2)Looking for participantsNCT05101070
What this trial is testing

S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Shionogi 282
Large-scale testing (Phase 3)UnknownNCT05910970
What this trial is testing

Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation

Who this might be right for
Hepatocellular CarcinomaRecurrenceImmune Checkpoint Inhibitor
Guangxi Medical University 200
Testing effectiveness (Phase 2)Ended earlyNCT03993379
What this trial is testing

PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid Tumors

Who this might be right for
Solid TumorUnresectable or Metastatic Melanoma
CytomX Therapeutics 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07134413
What this trial is testing

QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC

Who this might be right for
NSCLC
Guangdong Association of Clinical Trials 77
Testing effectiveness (Phase 2)UnknownNCT05143099
What this trial is testing

Phase II Study of Tislelizumab Combined With Cetuximab and Irinotecan in the Treatment of Recurrent, Refractory mCRC

Who this might be right for
Colorectal Neoplasms
Shanghai Zhongshan Hospital 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07599111
What this trial is testing

Exploratory Study on the Efficacy and Safety of Nebulized hUC-MSC-Derived Exosomes for Non-Acute CIP

Who this might be right for
Pneumonitis, InterstitialImmune Checkpoint Inhibitors (ICIs)Mesenchymal Stem Cells+1 more
Zhou Chengzhi 40
Large-scale testing (Phase 3)Looking for participantsNCT06581406
What this trial is testing

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
Replimune, Inc. 280
Not applicableTemporarily pausedNCT06508034
What this trial is testing

Probiotics for the Prevention of Immunotherapy Induced Colitis in Patients Receiving Immunotherapy

Who this might be right for
Malignant Solid Neoplasm
Mayo Clinic 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07267234
What this trial is testing

PRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0)

Who this might be right for
Solid CancerLymphopeniaRadiotherapy+1 more
Second Affiliated Hospital of Soochow University 65
Not applicableWithdrawnNCT05653531
What this trial is testing

Clinical Significance of Hepatic Biomarkers in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Who this might be right for
Immune Checkpoint InhibitorLung CancerLiver Biomarkers+1 more
Centre Hospitalier Universitaire, Amiens
Not applicableLooking for participantsNCT05718492
What this trial is testing

The Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 100
Load More Results